GeoVax Responds to New Mpox Variant, Highlights Vaccine Supply Concerns and Accelerated Development Program
GeoVax Labs addresses the emergence of a new recombinant Mpox strain and the global reliance on a single vaccine supplier, emphasizing the importance of its accelerated GEO-MVA program for domestic manufacturing and supply diversification.
Read the full story
























